Our Global Initiatives

Angiogenesis is the common denominator impacting more than 70 diseases.

Angiogenesis is a critical factor impacting more than 70 diseases, including cancer, heart disease, obesity, blindness, diabetes, chronic wounds, Alzheimer’s and many more. When angiogenesis is out of balance, meaning there is either too much or too little blood vessel growth, disease can emerge. Keeping angiogenesis in balance within the body is one of our key defenses against disease.

Educating patients, caregivers, clinicians and advocates

We believe better information leads to better health outcomes. Our global, patient-centered initiatives educate key stakeholders about the important role of angiogenesis in disease and health. Our key initiatives focus on preventing vision loss, defeating cancer and use diet and lifestyle to protect health. Many of our campaigns are also translated into Spanish, French, Italian, German, Japanese and Portuguese for increased reach.

Eat to Beat is an information hub where 60,000 people spanning 189 countries are learning how to use foods, beverages, and ingredients to starve cancers. Based on the latest medical science, Eat to Beat gives people practical, healthy, and tasty choices they can make everyday, at every meal, to incorporate cancer-fighting bioactives into their diet. This resource is built on our own research as well as the latest research published in peer-reviewed journals.
Do It Yourself Health is a resource for people who want to take control of their health through diet and lifestyle interventions, rooted in scientific evidence. It gives people the information they need for evidence-based decision-making to positively impact health and wellness. Discover easy and actionable ways to prevent and fight disease by eating, moving, sleeping and smiling.


Ang-2 plays an important role in retinal disorders, including AMD, DME, and RVO. Retinal vascular disease is about much more than VEGF, and targeting VEGF doesn’t cure these diseases. The interplay of the Ang-2/Tie2 signaling pathway with VEGF and other cellular components plays an important role in multiple retinal disorders. Ang-2 is the facilitator of multiple cellular activities which mediate vascular leakage, pericyte detachment, inflammation, and neovascularization.


The Science of AMD focuses on increasing international public and patient awareness of age-related macular degeneration (AMD), the role of angiogenesis in vision loss, and the importance of antiangiogenic treatments for saving vision. The goal of the campaign is to help people around the world living with AMD have the highest quality of life possible.
The Science of DME advocacy campaign focuses on increasing global public awareness of diabetic macular edema (DME), the role of vascular endothelial growth factor (VEGF) in DME, and the benefits of anti-VEGF treatments for people living with DME.
The Science of CRC focuses on increasing international public and patient awareness of colorectal cancer (CRC), the role of angiogenesis (new blood vessel growth) in tumor development, and the importance of antiangiogenic treatments for treating CRC. It aims to help people affected by CRC worldwide have the best possible health outcomes.
The Science of RVO advocacy campaign provides accurate, easy-to-understand, and useful information about retinal vein occlusion (RVO), and the evidence supporting anti-VEGF therapy for CRVO. We believe everyone affected by CRVO can be empowered with knowledge of relevant treatments and the practical steps they can take to fight vision loss.
The Eye Can Do It advocacy campaign is a patient-friendly web resource about vision loss for people living with diabetes. This site features an e-book outlining how to protect your vision when diagnosed with diabetes, resources to consult for continued care, and the latest in treatment options. Connect with the Eye Can Do It community to get up-to-date information about news, events, and research impacting vision in the diabetic community.